| Mr James Rystedt, RPH | |
|
440 Cherry St, Grafton, ND 58237-1737 | |
| (701) 352-2742 | |
| Not Available |
| Full Name | Mr James Rystedt |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 440 Cherry St, Grafton, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932318136 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2760 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr James Rystedt, RPH 440 Cherry St, Grafton, ND 58237-1737 Ph: (701) 352-2742 | Mr James Rystedt, RPH 440 Cherry St, Grafton, ND 58237-1737 Ph: (701) 352-2742 |
News Archive
The University of Texas MD Anderson Cancer Center and Pfizer will collaborate in the development of immune-based approaches to cancer treatment, the first such agreement made through MD Anderson's Moon Shots Program immunotherapy platform.
Amgen today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion to extend the marketing authorization for Vectibix (panitumumab) to include combination with FOLFIRI (an irinotecan-based chemotherapy) as first-line treatment in adult patients with wild-type RAS metastatic colorectal cancer (mCRC).
Last year's National Review of Asthma Deaths highlighted prescribing errors in nearly half of asthma deaths in primary care (47%). Now new analysis from Asthma UK, based on data from over 500 UK GP practices, reveals evidence that over 22,000 people with asthma in the UK, including 2,000 children, have been prescribed medicines (long-acting reliever inhalers) in a way that is so unsafe they have a ‘black box warning' in the USA due to the risk they pose to the lives of people with asthma.
Essentialis announced today the dosing of the first patient in clinical study PC025, which is designed to evaluate the safety and efficacy of diazoxide choline controlled release tablets (DCCR) in obese Prader-Willi syndrome patients.
Intact Vascular, a medical device company and developer of products for minimally invasive peripheral vascular procedures, today announced its European notified body has granted the company ISO Certification and CE Mark approval for Tack-it Endovascular Stapler device.
› Verified 1 days ago
Sandra Leigh Offutt, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 W 6th St, Pharmacy Dept - Health Service Center, Grafton, ND 58237 Phone: 701-352-4216 Fax: 701-352-4439 | |
Jordan Marie Peterson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 737 W 12th St, Grafton, ND 58237 Phone: 701-352-1760 Fax: 701-352-1761 | |
Mrs. Kari Pastorek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 E 12th St, Grafton, ND 58237 Phone: 701-352-0831 Fax: 701-352-1910 | |
Dr. Jenna Anne Midgarden, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 E 12th St, Grafton, ND 58237 Phone: 701-325-0831 Fax: 701-352-1910 | |
Mikayla Beth Fingarson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 E 12th St, Grafton, ND 58237 Phone: 701-352-0831 Fax: 701-352-1910 | |
Mrs. Beth Wharam, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 E 12th St, Grafton, ND 58237 Phone: 701-352-0831 | |
Sooyoon Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 737 W 12th St, Grafton, ND 58237 Phone: 701-352-1760 |